KR100606533B1 - An improved synthetic method of sibutramine - Google Patents

An improved synthetic method of sibutramine Download PDF

Info

Publication number
KR100606533B1
KR100606533B1 KR1020040067981A KR20040067981A KR100606533B1 KR 100606533 B1 KR100606533 B1 KR 100606533B1 KR 1020040067981 A KR1020040067981 A KR 1020040067981A KR 20040067981 A KR20040067981 A KR 20040067981A KR 100606533 B1 KR100606533 B1 KR 100606533B1
Authority
KR
South Korea
Prior art keywords
chlorophenyl
cyclobutyl
sibutramine
cyanide
yield
Prior art date
Application number
KR1020040067981A
Other languages
Korean (ko)
Other versions
KR20060019351A (en
Inventor
김종권
조현성
권혁일
이준환
Original Assignee
한올제약주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한올제약주식회사 filed Critical 한올제약주식회사
Priority to KR1020040067981A priority Critical patent/KR100606533B1/en
Publication of KR20060019351A publication Critical patent/KR20060019351A/en
Application granted granted Critical
Publication of KR100606533B1 publication Critical patent/KR100606533B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/24Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/25Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

본 발명은 시부트라민의 개선된 합성방법에 관한 것으로, 본 발명에서는 종래 시부트라민의 합성방법에 있어서 세 단계로 진행되던 반응을 한 단계로 진행시켜 공정을 크게 줄이고, 종래 합성방법의 고온증류 과정을 생략하고 바로 다음 단계를 진행함으로써 대량생산을 가능하게 하며, 이밖에도 단계별 공정개선을 이루어 수율은 크게 증가시키고 생산소요시간과 생산비를 크게 절감시킨 개선된 합성방법이 제공된다. 본 발명에 따르면 전체 수율면에서 종래 합성방법의 3배에 가까운 수율 개선효과를 보여 생산 원가를 크게 낮출 수 있다. The present invention relates to an improved method for synthesizing sibutramine, and in the present invention, the reaction proceeded in three steps in the conventional method for synthesizing sibutramine in one step, greatly reducing the process, and omitting the high temperature distillation process of the conventional synthesis method. Proceed to the next step, mass production is possible. In addition, step-by-step process improvements provide an improved synthesis method that greatly increases yield and significantly reduces production time and production costs. According to the present invention, the production yield can be greatly reduced by showing a yield improvement effect nearly three times that of the conventional synthesis method in terms of overall yield.

시부트라민, sibutramine, 비만치료제, 합성방법, 공정개선Sibutramine, sibutramine, obesity drug, synthetic method, process improvement

Description

시부트라민의 개선된 합성방법 {AN IMPROVED SYNTHETIC METHOD OF SIBUTRAMINE}Improved Synthesis of Sibutramine {AN IMPROVED SYNTHETIC METHOD OF SIBUTRAMINE}

본 발명은 시부트라민의 개선된 합성방법에 관한 것으로, 특히 공정을 크게 줄이고 반응조건을 용이하게 하면서도 수율을 향상시킨 시부트라민의 개선된 합성방법에 관한 것이다. The present invention relates to an improved method for synthesizing sibutramine, and more particularly, to an improved method for synthesizing sibutramine which greatly improves the yield while greatly reducing the process and facilitating reaction conditions.

시부트라민 염산염(Sibutramine HCl : C17H26CIN HCl)은 화학명 {1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}-디메틸아민 염산염으로, 하기 화학식 1의 구조를 갖는다. Sibutramine hydrochloride (Sibutramine HCl: C 17 H 26 CIN HCl) is a chemical name {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutyl} -dimethylamine hydrochloride, and has the structure of Formula 1 .

Figure 112004038703885-pat00001
Figure 112004038703885-pat00001

시부트라민은 본래 우울증 치료제로 개발되던 중 이 약을 복용한 환자의 체 중이 준다는 사실이 발견되어 비만치료제로 개발된 약물로, 뇌에서 식욕을 조절하는 신경호르몬인 세로토닌과 노르아드레날린의 재흡수를 억제시켜 식욕을 떨어뜨리게 한다. Sibutramine was originally developed as a drug for the treatment of depression and was found to give weight to patients taking this drug. It was developed as an anti-obesity drug. Let your appetite decrease.

대한민국 특허공보 특1990-274호(대응특허 DE3212682 (Boots), 1982.10.21. 출원; 우선권 GB 1981.4.6.)에 시부트라민을 포함하는 1-(1-아릴사이클로부틸)알킬아민 유도체의 제조방법이 기재되어 있다. 본 문헌에 기재된 시부트라민의 합성 방법은 다음과 같이 총 5단계로 진행된다.Korean Patent Publication No. 1990-274 (corresponding patent DE3212682 (Boots), filed Oct. 21, 1982; priority GB 1981.4.6.) For the preparation of 1- (1-arylcyclobutyl) alkylamine derivative comprising sibutramine It is described. The method for synthesizing sibutramine described in this document proceeds in a total of five steps as follows.

제 1 단계First step

Figure 112004038703885-pat00002
Figure 112004038703885-pat00002

4-클로로벤질 시아나이드(4-Chlorobenzyl cyanide)로부터 1-(4-클로로페닐)-1-사이클로부틸 시아나이드를 얻는다. 본 문헌에 기재된 실제 합성방법의 예는 다음과 같다.1- (4-chlorophenyl) -1-cyclobutyl cyanide is obtained from 4-Chlorobenzyl cyanide. Examples of the actual synthesis method described in this document are as follows.

4-클로로벤질 시아나이드 25g과 1,3-디브로모프로판 15㎖를 DMSO 150㎖에 용해시킨 후 이 용액을 질소하에 실온(20-35℃)에서 광유(mineral oil) 중에 분산된 NaH 7.5g과 DMSO 200㎖의 교반혼합물에 적가한다. 혼합물을 실온에서 2시간 교반 하고 IPA 8㎖를 적가한 후 물 110㎖를 적가한다. 혼합물을 셀라이트(CELITE™)로 여과시킨 후 고체 잔사를 에테르로 세척한다. 에테르 층을 분리하고 물로 세척하고 건조, 증발시킨 후, 고온에서 진공 증류시켜 목적하는 1-(4-클로로페닐)-1-사이클로부틸 시아나이드를 분리시킨다. 본 단계의 총 반응시간은 5시간이며, 출발물질로부터의 수율은 78%이다. After dissolving 25 g of 4-chlorobenzyl cyanide and 15 ml of 1,3-dibromopropane in 150 ml of DMSO, the solution was dissolved in nitrogen at room temperature (20-35 ° C.) and 7.5 g of NaH dispersed in mineral oil. And 200 ml of DMSO was added dropwise. The mixture was stirred at room temperature for 2 hours, 8 ml of IPA was added dropwise, and 110 ml of water was added dropwise. The mixture is filtered through CELITE ™ and the solid residue is washed with ether. The ether layer is separated, washed with water, dried, evaporated and vacuum distilled at high temperature to separate the desired 1- (4-chlorophenyl) -1-cyclobutyl cyanide. The total reaction time of this step is 5 hours and the yield from the starting material is 78%.

제 2 단계2nd step

Figure 112004038703885-pat00003
Figure 112004038703885-pat00003

1-(4-클로로페닐)-1-사이클로부틸 시아나이드로부터 1-[1-(4-클로로페닐)-시아노부틸]-3-메틸-부탄-1-온을 얻는다. 구체적인 합성예는 다음과 같다. 1-(4-클로로페닐)-1-사이클로부틸 시아나이드 35.2g을 에테르 100㎖ 중에 용해시키고 이 용액을 프로필브로마이드 32g과 마그네슘 6.36g과의 반응으로 제조된 생성물에 가한다. 에테르를 톨루엔으로 대치하고 혼합물을 환류하에 1시간 동안 가열한다. 물을 가한 후 농염산을 가하고, 혼합물을 환류하에 1시간 동안 가열한다. 전 단계와 마찬가지 방법으로 얻어진 혼합물을 에테르, 물로 처리하고 건조, 증발시킨 후 진공 증류시켜 목적하는 1-[1-(4-클로로페닐)-시아노부틸]-3-메틸-부탄-1-온을 분리시킨다. 본 단계의 반응시간은 총 22시간이며, 수율은 81%이다. 목적물은 bp 100-120℃/0.2 ㎜/Hg 이다. 1- [1- (4-chlorophenyl) -cyanobutyl] -3-methyl-butan-1-one is obtained from 1- (4-chlorophenyl) -1-cyclobutyl cyanide. Specific synthesis examples are as follows. 35.2 g of 1- (4-chlorophenyl) -1-cyclobutyl cyanide are dissolved in 100 ml of ether and this solution is added to the product prepared by the reaction of 32 g of propylbromide and 6.36 g of magnesium. The ether is replaced with toluene and the mixture is heated under reflux for 1 hour. After adding water, concentrated hydrochloric acid is added, and the mixture is heated under reflux for 1 hour. The mixture obtained in the same manner as in the previous step was treated with ether, water, dried and evaporated and then vacuum distilled to give the desired 1- [1- (4-chlorophenyl) -cyanobutyl] -3-methyl-butan-1-one. To separate. The reaction time of this step is a total of 22 hours, the yield is 81%. The target product is bp 100-120 ° C / 0.2 mm / Hg.

제 3 단계3rd step

Figure 112004038703885-pat00004
Figure 112004038703885-pat00004

1-[1-(4-클로로페닐)-시아노부틸]-3-메틸-부탄-1-온으로부터 N-{1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}포름아미드를 얻는다. 구체적인 합성예는 다음과 같다. 포름아미드 23.5㎖에, 1-[1-(4-클로로페닐)-시아노부틸]-3-메틸-부탄-1-온 37g(0.14mol)과 HCOOH 9㎖를 160-170℃에서 적가한다. 온도를 175℃ 내지 180℃에서 24시간 동안 유지시킨다. 혼합물을 에테르로 추출하고 농축하여 오일을 수득하고, 석유 에테르로부터 목적하는 N-{1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}포름아미드를 결정화한다. 본 단계의 반응시간은 총 24시간이며, 수율은 39%이다. 목적물은 mp 110-112℃ 이다. N- {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutyl from 1- [1- (4-chlorophenyl) -cyanobutyl] -3-methyl-butan-1-one } Formamide is obtained. Specific synthesis examples are as follows. To 23.5 ml of formamide, 37 g (0.14 mol) of 1- [1- (4-chlorophenyl) -cyanobutyl] -3-methyl-butan-1-one and 9 ml of HCOOH were added dropwise at 160-170 ° C. The temperature is maintained at 175 ° C. to 180 ° C. for 24 hours. The mixture is extracted with ether and concentrated to afford an oil, which crystallizes the desired N- {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutyl} formamide from petroleum ether. The reaction time of this step is a total of 24 hours, the yield is 39%. The target is mp 110-112 ° C.

제 4 단계4th step

Figure 112004038703885-pat00005
Figure 112004038703885-pat00005

N-{1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}포름아미드로부터 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민 염산염을 얻는다. 구체적인 합성예는 다음과 같다. N-{1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}포름아미드 4g, 2-메톡시에틸 에테르 25㎖, 물 10㎖, 농염산 22㎖를 18시간 동안 환류하에 교반한다. 물로 희석하고, 에테르로 세척하고, 5M NaOH 수용액 35㎖를 가한다. 에테르, 물, 식염수로 처리하여 공정을 마무리한 후 황산마그네슘으로 처리하고 여과한 후 농축한다. 농축된 조생성물을 에테르 20㎖에 녹인 염산으로 포화시킨다. 생성된 고형물을 여과, 농축하고 석유 에테르로 결정화하여 목적물인 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민 염산염을 얻는다. 본 단계의 반응시간은 총 20시간이며, 수율은 오일 96%, 염산염 46%이다. 목적물은 mp 163-165℃ 이다. 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine hydrochloride from N- {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutyl} formamide Get Specific synthesis examples are as follows. 4 g of N- {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutyl} formamide, 25 ml of 2-methoxyethyl ether, 10 ml of water and 22 ml of concentrated hydrochloric acid were refluxed for 18 hours. Stir under. Dilute with water, wash with ether, and add 35 ml of 5M aqueous NaOH solution. After completion of the process by treatment with ether, water and brine, treated with magnesium sulfate, filtered and concentrated. The concentrated crude product is saturated with hydrochloric acid dissolved in 20 ml of ether. The resulting solid is filtered, concentrated and crystallized with petroleum ether to give the desired product 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine hydrochloride. The reaction time of this step is a total of 20 hours, the yield is 96% oil, 46% hydrochloride. The target product is mp 163-165 ° C.

제 5 단계5th step

Figure 112004038703885-pat00006
Figure 112004038703885-pat00006

1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민 염산염으로부터 최종 목적물인 {1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}-디메틸아민 염산염, 즉 시부트라민 염산염을 얻는다. 구체적인 합성예는 다음과 같다. 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민 염산염 3.3g, HCOOH 2.99g 및 물 1㎖를 냉각시키면서 혼합한다. 37% 수성 포름알데히드 3.93㎖를 가하고 85-95℃에서 18시간 동안 가열한다. 과량의 염산을 가하고 용액을 증발 건조시킨다. 5N NaOH 용액을 가하고, 에테르로 추출하고 농축하여 담황색의 오일을 수득한다. 이 오일을 IPA 4㎖, 에테르 20㎖의 혼합물에 용해시키고 염산 2㎖를 적가한다. 농축하고, 에탄올에 반복적으로 용해시키고, 다시 농축한다. 석유 에테르로 연마하여 황색고체를 수득하고 아세톤으로 재결정시켜 최종 목적물인 시부트라민 염산염을 얻는다. 본 단계의 반응시간은 총 18시간이며, 수율은 80%이다. 목적물은 mp 195-197℃ 이다. 다섯 단계 전체 수율은 18.9%이다. The final target from 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine hydrochloride {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutyl} -dimethyl Amine hydrochloride, ie sibutramine hydrochloride, is obtained. Specific synthesis examples are as follows. 3.3 g of 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine hydrochloride, 2.99 g of HCOOH and 1 ml of water are mixed while cooling. 3.93 ml of 37% aqueous formaldehyde is added and heated at 85-95 ° C. for 18 hours. Excess hydrochloric acid is added and the solution is evaporated to dryness. 5N NaOH solution is added, extracted with ether and concentrated to give a pale yellow oil. This oil is dissolved in a mixture of 4 mL IPA, 20 mL ether and 2 mL hydrochloric acid is added dropwise. Concentrate, repeatedly dissolve in ethanol and concentrate again. Polishing with petroleum ether gives a yellow solid and recrystallizes with acetone to give the final target sibutramine hydrochloride. The reaction time of this step is a total of 18 hours, the yield is 80%. The target product is mp 195-197 ° C. The overall yield for the five stages is 18.9%.

상기와 같은 종래의 시부트라민 합성방법은, 총 다섯 단계를 거치도록 되어 있어 공정이 복잡하고 시간이 오래 걸리며, 고온의 진공 증류(제1단계)를 요하는 등 정제조건이 까다로워 대량생산이 어렵고, 고온조건에서 반응을 진행시키므로 원료의 고온 변성으로 수율이 감소한다는 문제점이 있었다. 실제 종래의 시부트라민 합성방법을 적용하여 합성을 수행한 결과 전체수율이 18.9%로 매우 낮게 나왔다.As described above, the conventional sibutramine synthesis method has a total of five steps, which makes the process complicated and time-consuming, and requires high temperature vacuum distillation (first step). Since the reaction proceeds under the conditions there was a problem that the yield is reduced by high temperature modification of the raw material. In fact, the synthesis was performed by applying the conventional sibutramine synthesis method, the total yield was very low as 18.9%.

이에 본 발명은 종래 시부트라민의 복잡한 합성방법을 개선하여 공정을 간소화하고, 대량생산이 가능하도록 반응조건을 용이하게 하며, 수율을 크게 향상시키는 것을 목적으로 한다. Accordingly, the present invention aims to simplify the process by improving the conventional method of synthesizing sibutramine, to facilitate the reaction conditions to enable mass production, and to greatly improve the yield.

특히 본 발명에서는, 종래 시부트라민의 합성방법에 있어서 제2단계, 제3단계, 제4단계의 세 단계로 진행되던 반응을 한 단계로 진행시켜 공정을 크게 줄이고, 종래 합성방법의 고온증류 과정(제1단계)을 생략하고 바로 다음 단계를 진행함으로써 대량생산을 가능하게 하며, 이밖에도 단계별 공정개선을 이루어 수율은 크게 증가시키고 생산소요시간과 생산비는 크게 절감시킨 개선된 합성방법을 제공하고자 한다. In particular, in the present invention, in the conventional method for synthesizing sibutramine, the reaction proceeded in three steps of the second step, the third step, and the fourth step in one step to greatly reduce the process, and the high temperature distillation process of the conventional synthesis method (see By eliminating step 1), the next step is to proceed to the next step, and mass production is possible. In addition, step by step process improvement is intended to provide an improved synthesis method which greatly increases the yield and greatly reduces the production time and production cost.

본 발명의 다른 목적 및 장점들은 하기에 설명될 것이며, 본 발명의 실시에 의해 더 잘 알게 될 것이다.
Other objects and advantages of the invention will be described below, and will be better understood by practice of the invention.

본 발명에서는,In the present invention,

4-클로로벤질 시아나이드(4-Chlorobenzyl cyanide)로부터 {1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}-디메틸아민을 합성하는 방법에 있어서,In the method for synthesizing {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutyl} -dimethylamine from 4-chlorobenzyl cyanide,

(a) 4-클로로벤질 시아나이드(4-Chlorobenzyl cyanide)와 1,3-디브로모프로판을 반응시켜 1-(4-클로로페닐)-1-사이클로부틸 시아나이드를 얻는 단계와; (a) reacting 4-chlorobenzyl cyanide with 1,3-dibromopropane to obtain 1- (4-chlorophenyl) -1-cyclobutyl cyanide;

(b) 톨루엔에 용해시킨 1-(4-클로로페닐)-1-사이클로부틸 시아나이드에, 디에틸에테르에 용해시킨 이소부틸마그네슘 브로마이드를 가하고, 이 혼합물을 105℃ 이상의 온도에서 환류하에 1-3 시간 가열하고, 냉각시킨 후 0-25℃에서 NaBH4를 가하고 1시간 이상 교반 반응시켜 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민을 얻는 단계와;(b) To isobutyl magnesium bromide dissolved in diethyl ether is added to 1- (4-chlorophenyl) -1-cyclobutyl cyanide dissolved in toluene, and the mixture is refluxed at a temperature of 105 ° C. or higher at 1-3 ° C. Heating and cooling for a period of time, followed by addition of NaBH 4 at 0-25 ° C., followed by stirring for at least 1 hour to obtain 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine;

(c) 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민의 아민기를 디메틸화하여 {1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}-디메틸아민을 얻는 단계;를 포함하는 3단계 반응으로 이루어진 시부트라민의 개선된 합성방법이 제공된다. (c) Dimethylating the amine group of 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine to yield {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methyl There is provided an improved method for synthesizing sibutramine consisting of a three step reaction comprising: obtaining butyl} -dimethylamine.

본 발명의 시부트라민 합성방법은 종래 시부트라민의 합성방법에서, 제2단계, 즉 (1-(4-클로로페닐)-1-사이클로부틸 시아나이드로부터 1-[1-(4-클로로페닐)-시아노부틸]-3-메틸-부탄-1-온을 얻는 단계; 제3단계, 즉 1-[1-(4-클로로페닐)-시아노부틸]-3-메틸-부탄-1-온으로부터 N-{1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}포름아미드를 얻는 단계; 제4단계, 즉 N-{1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}포름아미드로부터 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민 염산염을 얻는 세 단계를 하나의 단계, 즉 상기 단계(b)로 단순한 것으로 공정을 획기적으로 단축한 것이다. Sibutramine synthesis method of the present invention in the conventional method for synthesizing sibutramine, the second step, that is 1- [1- (4-chlorophenyl) -cyano from (1- (4-chlorophenyl) -1-cyclobutyl cyanide Butyl] -3-methyl-butan-1-one; the third step, ie N- from 1- [1- (4-chlorophenyl) -cyanobutyl] -3-methyl-butan-1-one Obtaining {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutyl} formamide; the fourth step, ie N- {1- [1- (4-chlorophenyl) -cyclobutyl ] 3-methylbutyl} formamide to obtain 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine hydrochloride in one step, i.e. The process is dramatically shortened.

또 본 발명에서는, 종래 합성방법의 제1단계에서 고온증류 과정을 생략하고 다음 단계를 진행함으로써 대량생산을 가능하게 하는 등의 단계별 공정개선을 이루어 수율은 크게 증가시키고 생산소요시간과 생산비를 크게 절감시킨 개선된 합성방법을 제공한다. 즉, 상기 단계(a)에서, DMSO에 4-클로로벤질 시아나이드와 1,3-디브로모프로판을 용해시킨 용액을, 광유(mineral oil) 중에 분산된 NaH와 DMSO의 혼합물에 적가하여 반응시킨 후 여과, 세척, 농축, 건조하여 1-(4-클로로페닐)-1-사이클로부틸 시아나이드의 조생성물을 얻고, 이 조생성물을 고온의 증류 과정 없이 그대로 다음 단계(b)를 진행시켜 까다로운 공정을 개선하고, 하기에서 확인되는 바와 같이 오히려 수율은 증가시키게 된다. In addition, in the present invention, by increasing the yield step by step, such as enabling the mass production by skipping the high-temperature distillation process in the first step of the conventional synthesis method, and proceeding to the next step, the yield is greatly increased and the production time and production costs are greatly reduced. Improved synthesis methods are provided. That is, in step (a), a solution of 4-chlorobenzyl cyanide and 1,3-dibromopropane dissolved in DMSO is added dropwise to a mixture of NaH and DMSO dispersed in mineral oil to react. After filtration, washing, concentration, and drying, a crude product of 1- (4-chlorophenyl) -1-cyclobutyl cyanide was obtained, and the crude product was subjected to the next step (b) as it is without high temperature distillation. And yields are increased as can be seen below.

또 본 발명에서는, 상기 단계(c)에서, 종래기술과 달리 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민을 염기(free base) 상태에서 포름산과 혼합한 후 37% 수성 포름알데히드를 가하고 85-95℃에서 15-22 시간 가열반응시킨 후 염산을 가하여 시부트라민 염산염을 얻는다. 즉, 본 발명은 종래기술과 달리 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민을 염산염이 아닌 염기(free base) 상태에 반응시키게 됨으로써 용해성을 훨씬 향상시킬 수 있고 물을 사용하는 번거로움을 피할 수 있다. In the present invention, in step (c), after mixing 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine with formic acid in a free base state, unlike the prior art, 37% aqueous formaldehyde is added and heated at 85-95 ° C. for 15-22 hours followed by hydrochloric acid to obtain sibutramine hydrochloride. That is, the present invention can improve the solubility by reacting 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine in a free base state rather than hydrochloride, unlike the prior art. And avoid the hassle of using water.

상기와 같이 본 발명은 종래 세 단계로 진행되던 반응을 효율적인 한 단계 반응으로 개선하여 공정을 크게 줄이는 것은 물론, 이밖에도 단계별 공정개선을 이루어 생산소요시간과 생산비를 크게 절감시키고 있으며, 하기에 설명하는 본 발명의 바람직한 실시예에 따르면 공정 전체의 총 수율이 52.7%로 종래 합성방법의 18.9%에 비해 거의 3배 가까이 수율이 향상되고 있다. As described above, the present invention improves the reaction which was performed in the conventional three steps to an efficient one-step reaction, thereby greatly reducing the process, and in addition to the step-by-step process improvement, greatly reducing the production time and production cost, which will be described below. According to a preferred embodiment of the present invention, the overall yield is 52.7%, and the yield is improved almost three times compared to 18.9% of the conventional synthesis method.

이하, 본 발명의 시부트라민 합성방법을 각 단계별로 바람직한 실시예를 들어 상세히 설명한다. 그러나 다음의 바람직한 실시예에 의해 본 발명의 범위가 한정되는 것은 아니며, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에 의해 본 발명의 기술사상과 아래에 기재될 특허청구범위의 균등범위내에서 다양한 수정 및 변형이 가능한 것은 물론이다. Hereinafter, the sibutramine synthesis method of the present invention will be described in detail with reference to preferred examples for each step. However, the scope of the present invention is not limited by the following preferred embodiments, and those skilled in the art to which the present invention pertains should be within the equivalent scope of the technical spirit of the present invention and the claims to be described below. Of course, various modifications and variations are possible.

단계 AStep A

4-클로로벤질 시아나이드(4-Chlorobenzyl cyanide)와 1,3-디브로모프로판을 반응시켜 1-(4-클로로페닐)-1-사이클로부틸 시아나이드를 얻는다. 4-Chlorobenzyl cyanide is reacted with 1,3-dibromopropane to give 1- (4-chlorophenyl) -1-cyclobutyl cyanide.

Figure 112004038703885-pat00007
Figure 112004038703885-pat00007

실온(20-35℃)에서 플라스크에 광유(mineral oil) 중에 분산(60%)된 NaH 14.1g(352mmol)과 DMSO 200㎖를 넣고, 4-클로로벤질 시아나이드 25g(160mmol)과 1,3-디브로모프로판 36g(176mmol)을 DMSO 200㎖에 용해시킨 용액을 적가한다. 혼합물을 실온에서 2시간 교반하고 IPA 10㎖를 적가한 후 물 200㎖를 적가한다. 혼합물을 셀라이트(CELITE™) 필터로 여과한 후 고체 잔사를 에테르로 세척한다. 에테르 층을 분리하고 물로 세척한 후 여과, 농축, 건조하여 1-(4-클로로페닐)-1-사이클로부틸 시아나이드의 조생성물을 34.72g 얻는다. 조생성물의 수율은 109.8%이다. In a flask at room temperature (20-35 ° C.), 14.1 g (352 mmol) of NaH dispersed in mineral oil (200%) and 200 ml of DMSO were added. 25 g (160 mmol) of 4-chlorobenzyl cyanide and 1,3- A solution of 36 g (176 mmol) of dibromopropane dissolved in 200 ml of DMSO was added dropwise. The mixture is stirred at room temperature for 2 hours, 10 ml of IPA is added dropwise and 200 ml of water is added dropwise. The mixture is filtered through a CELITE ™ filter and the solid residue is washed with ether. The ether layer is separated, washed with water, filtered, concentrated and dried to give 34.72 g of crude product of 1- (4-chlorophenyl) -1-cyclobutyl cyanide. The yield of crude product is 109.8%.

단계 BStep B

1-(4-클로로페닐)-1-사이클로부틸 시아나이드와 이소부틸마그네슘 브로마이드를 반응시켜 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민을 얻는다. 1- (4-chlorophenyl) -1-cyclobutyl cyanide isobutyl magnesium bromide is reacted to obtain 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine.

Figure 112004038703885-pat00008
Figure 112004038703885-pat00008

실온에서 1-(4-클로로페닐)-1-사이클로부틸 시아나이드 10g(52mmol)을 톨루엔 25㎖에 녹인 다음, 디에틸에테르 40㎖에 용해시킨 이소부틸마그네슘 브로마이드 2.0M 용액을 가한다. 이 혼합물을 105℃ 이상의 온도에서 환류하에 2시간 동안 가열한다. 메탄올로 0℃에서 반응을 종결시킨 후 혼합물에 NaBH4 2.4g을 0-25℃에서 넣고 1시간 이상 교반한다. 농축하고 에테르, 물로 처리한 후 다시 농축하고 진공건조하여 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민 12g을 얻는다. 조생성물의 수득율은 91.6%이다. 10 g (52 mmol) of 1- (4-chlorophenyl) -1-cyclobutyl cyanide was dissolved in 25 ml of toluene at room temperature, followed by addition of a 2.0 M solution of isobutyl magnesium bromide dissolved in 40 ml of diethyl ether. The mixture is heated at reflux at a temperature of at least 105 ° C. for 2 hours. After completion of the reaction at 0 ° C. with methanol, 2.4 g of NaBH 4 was added to the mixture at 0-25 ° C. and stirred for 1 hour or more. Concentrate, treat with ether, water, concentrate again and dry under vacuum to obtain 12 g of 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine. The yield of crude product is 91.6%.

단계 CStep C

1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민의 아민기를 디메틸화하여 본 발명의 최종 목적물인 {1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}-디메틸아민 염산염, 즉 시부트라민 염산염을 얻는다. The amine group of 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine was dimethylated to obtain {1- [1- (4-chlorophenyl) -cyclobutyl]-which is the final object of the present invention. 3-methylbutyl} -dimethylamine hydrochloride, ie sibutramine hydrochloride, is obtained.

Figure 112004038703885-pat00009
Figure 112004038703885-pat00009

1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민 5.02g과 HCOOH 10㎖를 냉각시키면서 혼합한다. 37% 수성 포름알데히드 6㎖를 가하고 85-95℃에서 18시간 동안 가열한다. 과량의 2M HCl을 가하고 용액을 증발 건조시킨다. 5N NaOH 용액을 가하고, 에테르로 추출하고, 농축하여 담황색의 오일을 수득한다. 소량의 에테르에 녹인 후 HCl 가스로 포화된 에테르를 0℃에서 천천히 적가한다. 얻어진 고체를 여과하고 진공건조하여 최종 목적물인 시부트라민 염산염 5.12g을 얻는다. 생성물의 수율은 92%, mp 193.5-194.8℃이다. 단계 A 내지 C의 총 수율은 52.7%이다. 최종 생성물의 H1 NMR 결과는 다음과 같다 : H1 NMR(CDCl3) 1.058(6H,dd), 1.400(2H,m), 1.508(2H,m), 2.193(3H,d), 2.316(2H,m), 2.784(2H,m), 2.910(3H,d), 2.967(1H,m), 3.568(1H,m), 7.386(2H,d), 7.638(2H,d), 10.771(1H,s)5.02 g of 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine and 10 ml of HCOOH are mixed with cooling. 6 ml of 37% aqueous formaldehyde is added and heated at 85-95 ° C. for 18 hours. Excess 2M HCl is added and the solution is evaporated to dryness. 5N NaOH solution is added, extracted with ether and concentrated to give a pale yellow oil. After dissolving in a small amount of ether, ether saturated with HCl gas is slowly added dropwise at 0 ° C. The solid obtained was filtered and dried in vacuo to give 5.12 g of sibutramine hydrochloride as the final target. Yield of the product is 92%, mp 193.5-194.8 ° C. The total yield of steps A to C is 52.7%. The H 1 NMR results of the final product are as follows: H 1 NMR (CDCl 3 ) 1.058 (6H, dd), 1.400 (2H, m), 1.508 (2H, m), 2.193 (3H, d), 2.316 (2H , m), 2.784 (2H, m), 2.910 (3H, d), 2.967 (1H, m), 3.568 (1H, m), 7.386 (2H, d), 7.638 (2H, d), 10.771 (1H, s)

본 발명은 종래에 다섯 단계로 진행되던 공정을 3단계로 단축하여 공정을 크 게 단축하는 것은 물론 진행이 까다롭고 시간이 많이 소요되는 고온의 진공증류 공정을 생략할 수 있도록 하여 대량생산이 가능하도록 하였으며, 이밖에도 단계별 공정개선을 이루어 생산소요시간과 생산비를 크게 절감시키고 있으며, 전체 수율면에서 종래 합성방법의 3배에 가까운 수율 개선효과를 보여 생산 원가를 크게 낮출 수 있다. The present invention is to shorten the process that was conventionally carried out in five steps to three steps to greatly shorten the process as well as to eliminate the difficult and time-consuming high-temperature vacuum distillation process to enable mass production In addition, it is possible to greatly reduce production time and production costs by improving the process step by step, and to reduce the production cost by showing a yield improvement effect nearly three times that of the conventional synthesis method in terms of overall yield.

Claims (3)

4-클로로벤질 시아나이드(4-Chlorobenzyl cyanide)로부터 {1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}-디메틸아민을 합성하는 방법에 있어서,In the method for synthesizing {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutyl} -dimethylamine from 4-chlorobenzyl cyanide, (a) 4-클로로벤질 시아나이드(4-Chlorobenzyl cyanide)와 1,3-디브로모프로판을 반응시켜 1-(4-클로로페닐)-1-사이클로부틸 시아나이드를 얻는 단계와; (a) reacting 4-chlorobenzyl cyanide with 1,3-dibromopropane to obtain 1- (4-chlorophenyl) -1-cyclobutyl cyanide; (b) 톨루엔에 용해시킨 1-(4-클로로페닐)-1-사이클로부틸 시아나이드에, 디에틸에테르에 용해시킨 이소부틸마그네슘 브로마이드를 가하고, 이 혼합물을 105℃ 이상의 온도에서 환류하에 1-3 시간 가열하고, 냉각시킨 후 0-25℃에서 NaBH4를 가하고 1시간 이상 교반 반응시켜 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민을 얻는 단계와;(b) To isobutyl magnesium bromide dissolved in diethyl ether is added to 1- (4-chlorophenyl) -1-cyclobutyl cyanide dissolved in toluene, and the mixture is refluxed at a temperature of 105 ° C. or higher at 1-3 ° C. Heating and cooling for a period of time, followed by addition of NaBH 4 at 0-25 ° C., followed by stirring for at least 1 hour to obtain 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine; (c) 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민의 아민기를 디메틸화하여 {1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸}-디메틸아민을 얻는 단계;를 포함하는 3단계 반응으로 이루어진 시부트라민의 개선된 합성방법.(c) Dimethylating the amine group of 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine to yield {1- [1- (4-chlorophenyl) -cyclobutyl] -3-methyl Improved synthesis method of sibutramine consisting of a three-step reaction comprising the step of obtaining butyl} -dimethylamine. 청구항 1에 있어서,The method according to claim 1, 상기 단계(a)에서, DMSO에 4-클로로벤질 시아나이드와 1,3-디브로모프로판을 용해시킨 용액을, 광유(mineral oil) 중에 분산된 NaH와 DMSO의 혼합물에 적가하여 반응시킨 후 여과, 세척, 농축, 건조하여 1-(4-클로로페닐)-1-사이클로부틸 시아나이드의 조생성물을 얻고, 이 조생성물을 고온의 증류 과정 없이 그대로 다음 단계(b)를 진행시키는 것을 특징으로 하는 시부트라민의 개선된 합성방법.In step (a), the solution of 4-chlorobenzyl cyanide and 1,3-dibromopropane dissolved in DMSO is added dropwise to the mixture of NaH and DMSO dispersed in mineral oil, followed by filtration. , Washing, concentrating and drying to obtain a crude product of 1- (4-chlorophenyl) -1-cyclobutyl cyanide, and proceeding to the next step (b) as it is without distillation at high temperature. Improved Synthesis of Sibutramine. 청구항 1에 있어서,The method according to claim 1, 상기 단계(c)에서, 1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민을 염기(free base) 상태에서 포름산과 혼합한 후 37% 수성 포름알데히드를 가하고 85-95℃에서 15-22 시간 가열반응시킨 후 염산을 가하여 시부트라민 염산염을 얻는 것을 특징으로 하는 시부트라민의 개선된 합성방법. In step (c), 1- [1- (4-chlorophenyl) -cyclobutyl] -3-methylbutylamine is mixed with formic acid in the free base state, and then 37% aqueous formaldehyde is added and 85- An improved method for synthesizing sibutramine, characterized in that sibutramine hydrochloride is obtained by adding hydrochloric acid after heating at 95 ° C. for 15-22 hours.
KR1020040067981A 2004-08-27 2004-08-27 An improved synthetic method of sibutramine KR100606533B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020040067981A KR100606533B1 (en) 2004-08-27 2004-08-27 An improved synthetic method of sibutramine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040067981A KR100606533B1 (en) 2004-08-27 2004-08-27 An improved synthetic method of sibutramine

Publications (2)

Publication Number Publication Date
KR20060019351A KR20060019351A (en) 2006-03-03
KR100606533B1 true KR100606533B1 (en) 2006-08-01

Family

ID=37126760

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040067981A KR100606533B1 (en) 2004-08-27 2004-08-27 An improved synthetic method of sibutramine

Country Status (1)

Country Link
KR (1) KR100606533B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098602A (en) 1981-04-06 1982-11-24 Boots Co Plc Therapeutic agents
KR900005256B1 (en) * 1982-09-30 1990-07-21 더 부츠 캄파니 피이 엘 씨이 Process for preparing phenyl cyclo butyl methyl amine derivatives
US6476078B2 (en) * 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
KR20040067981A (en) * 2003-01-22 2004-07-30 혼다 기켄 고교 가부시키가이샤 Agricultural wheel tire

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098602A (en) 1981-04-06 1982-11-24 Boots Co Plc Therapeutic agents
KR900005256B1 (en) * 1982-09-30 1990-07-21 더 부츠 캄파니 피이 엘 씨이 Process for preparing phenyl cyclo butyl methyl amine derivatives
US6476078B2 (en) * 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
KR20040067981A (en) * 2003-01-22 2004-07-30 혼다 기켄 고교 가부시키가이샤 Agricultural wheel tire

Also Published As

Publication number Publication date
KR20060019351A (en) 2006-03-03

Similar Documents

Publication Publication Date Title
TWI580675B (en) Preparation of 4- [5- (pyridin-4-yl) -1H-1,2,4-triazol-3-yl] pyridine-2-carbonitrile and intermediates
RU2455281C2 (en) Method of producing 1-formamido-3,5-dimethyladamantane
KR100606533B1 (en) An improved synthetic method of sibutramine
KR100606534B1 (en) An improved synthetic method of sibutramine
JP2017149686A (en) Production method of ketoxime compound
KR101382102B1 (en) A preparation method of (S)-dapoxetine hydrochloride
JP5685594B2 (en) Method for producing cinacalcet
KR101757683B1 (en) Novel method for preparing trientine and HCl salts thereof
CN109160886B (en) Synthesis method of N-phenylbenzamide
DE69714858T2 (en) METHOD FOR PRODUCING CYANOCYCIC ACID AMIDES
JPS63145262A (en) Production of trifluoromethylbenzonitrile
CN111592488A (en) Method for efficiently preparing 4-dimethylaminopyridine
CN113501786B (en) Nylon monomer and preparation method thereof
KR101085170B1 (en) Method of Preparing S-Rivastigmine
RU2644946C1 (en) Method of producing methyl 3-[3-((cyclohexylcarbonyl){[4'-(dimethylamino)biphenyl-4-yl]methyl}amino)phenyl]acrylate(phexaramine) by liquid-phase method
JP4524365B2 (en) Method for producing asymmetric aliphatic tertiary amine
KR100407720B1 (en) Preparing Method for N-[3-{3-(1-Piperidinylmethyl)phenoxy}propyl]acetoxyacetamide
CN117105819A (en) Preparation method of intermediate of irbesartan isomer
JP4366854B2 (en) 12-amino-4,8-dodecadienenitrile and process for producing the same
JP4612974B2 (en) Method for producing benzylamine derivative
JP2007277232A (en) Method of nitration
JPS60132940A (en) Manufacture of alpha-substituted acrylic acid amide
Guillamon Daimiel Palladium-Catalyzed C–H bond functionalization for the synthesis of tetrahydroisoquinolines
KR100449750B1 (en) Process for the preparation of racemic alkyl 4-chloro-3-hydroxy butyrate
CN116675617A (en) Method for synthesizing acyclic tertiary amide

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130703

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20140703

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20150706

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee